289 related articles for article (PubMed ID: 29616828)
1. Zinc binding groups for histone deacetylase inhibitors.
Zhang L; Zhang J; Jiang Q; Zhang L; Song W
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):714-721. PubMed ID: 29616828
[TBL] [Abstract][Full Text] [Related]
2. Comparison of three zinc binding groups for HDAC inhibitors - A potency, selectivity and enzymatic kinetics study.
Yue K; Qin M; Huang C; James Chou C; Jiang Y; Li X
Bioorg Med Chem Lett; 2022 Aug; 70():128797. PubMed ID: 35580726
[TBL] [Abstract][Full Text] [Related]
3. Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases.
Frühauf A; Meyer-Almes FJ
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500583
[TBL] [Abstract][Full Text] [Related]
4. The Zinc-Binding Group Effect: Lessons from Non-Hydroxamic Acid Vorinostat Analogs.
Geurs S; Clarisse D; De Bosscher K; D'hooghe M
J Med Chem; 2023 Jun; 66(12):7698-7729. PubMed ID: 37276138
[TBL] [Abstract][Full Text] [Related]
5. Computational exploration of zinc binding groups for HDAC inhibition.
Chen K; Xu L; Wiest O
J Org Chem; 2013 May; 78(10):5051-5. PubMed ID: 23586590
[TBL] [Abstract][Full Text] [Related]
6. An efficient synthesis of SK-658 and its analogs as potent histone deacetylase inhibitors.
Shahidul Islam M; Nurul Islam M; Ashraful Hoque M; Nishino N; Kato T; Kim HJ; Ito A; Yoshida M
Bioorg Chem; 2015 Apr; 59():145-50. PubMed ID: 25797804
[TBL] [Abstract][Full Text] [Related]
7. Investigation on the ZBG-functionality of phenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase inhibitors.
Musso L; Cincinelli R; Zuco V; Zunino F; Nurisso A; Cuendet M; Giannini G; Vesci L; Pisano C; Dallavalle S
Bioorg Med Chem Lett; 2015 Oct; 25(20):4457-60. PubMed ID: 26376355
[TBL] [Abstract][Full Text] [Related]
8. Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget?
Shen S; Kozikowski AP
ChemMedChem; 2016 Jan; 11(1):15-21. PubMed ID: 26603496
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors.
De Vreese R; D'hooghe M
Eur J Med Chem; 2017 Jul; 135():174-195. PubMed ID: 28453994
[TBL] [Abstract][Full Text] [Related]
10. Diarylcyclopropane hydroxamic acid inhibitors of histone deacetylase 4 designed by combinatorial approach and QM/MM calculations.
Kollar J; Frecer V
J Mol Graph Model; 2018 Oct; 85():97-110. PubMed ID: 30145395
[TBL] [Abstract][Full Text] [Related]
11. Syntheses and Biological Evaluation of Novel Hydroxamic Acid Derivatives Containing Purine Moiety as Histone Deacetylase Inhibitors.
Xu Z; Yang Y; Mai X; Liu B; Xiong Y; Feng L; Liao Y; Zhang Y; Wang H; Ouyang L; Liu S
Chem Pharm Bull (Tokyo); 2018; 66(4):439-451. PubMed ID: 29607910
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors.
Senger J; Melesina J; Marek M; Romier C; Oehme I; Witt O; Sippl W; Jung M
J Med Chem; 2016 Feb; 59(4):1545-55. PubMed ID: 26653328
[TBL] [Abstract][Full Text] [Related]
13. The Development Process: from SAHA to Hydroxamate HDAC Inhibitors with Branched CAP Region and Linear Linker.
Yang F; Zhao N; Hu Y; Jiang CS; Zhang H
Chem Biodivers; 2020 Jan; 17(1):e1900427. PubMed ID: 31793143
[TBL] [Abstract][Full Text] [Related]
14. [Structure-activity relationships of histone deacetylase inhibitors].
Tan YM; Huang WY; Yu NF
Yao Xue Xue Bao; 2009 Oct; 44(10):1072-83. PubMed ID: 20055127
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of tyrosine-based hydroxamic acid analogs as novel histone deacetylases (HDACs) inhibitors.
Zhang Y; Feng J; Liu C; Fang H; Xu W
Bioorg Med Chem; 2011 Aug; 19(15):4437-44. PubMed ID: 21733698
[TBL] [Abstract][Full Text] [Related]
16. Hydroxamic Acid-Based Histone Deacetylase (HDAC) Inhibitors Bearing a Pyrazole Scaffold and a Cinnamoyl Linker.
Zagni C; Citarella A; Oussama M; Rescifina A; Maugeri A; Navarra M; Scala A; Piperno A; Micale N
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30795625
[TBL] [Abstract][Full Text] [Related]
17. Phosphorus containing analogues of SAHA as inhibitors of HDACs.
Pun MD; Wu HH; Olatunji FP; Kesic BN; Peters JW; Berkman CE
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1315-1319. PubMed ID: 35514164
[TBL] [Abstract][Full Text] [Related]
18. Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif.
Wagner FF; Olson DE; Gale JP; Kaya T; Weïwer M; Aidoud N; Thomas M; Davoine EL; Lemercier BC; Zhang YL; Holson EB
J Med Chem; 2013 Feb; 56(4):1772-6. PubMed ID: 23368884
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel histone deacetylase inhibitor derived from nuclear localization signal peptide.
Canzoneri JC; Chen PC; Oyelere AK
Bioorg Med Chem Lett; 2009 Dec; 19(23):6588-90. PubMed ID: 19854643
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor.
Luckhurst CA; Aziz O; Beaumont V; Bürli RW; Breccia P; Maillard MC; Haughan AF; Lamers M; Leonard P; Matthews KL; Raphy G; Stott AJ; Munoz-Sanjuan I; Thomas B; Wall M; Wishart G; Yates D; Dominguez C
Bioorg Med Chem Lett; 2019 Jan; 29(1):83-88. PubMed ID: 30463802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
